about
Novel bifunctional DATA chelator for quick access to site-directed PET (68)Ga-radiotracers: preclinical proof-of-principle with [Tyr(3)]octreotide.Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.Localization of Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological ResponsesComparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer PairInstant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC.New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative EvaluationClinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examplesTheranostic approaches in nuclear oncology: From bench to bedComparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stabilityKey-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands
P50
Q38694747-FC53E098-068C-40D6-934A-9A451DFA53DCQ52718831-27DBC50D-4734-4C1E-B314-C2FF56A08EA7Q64072212-8E76FDE0-10F3-41DF-A3A3-0EBAE5AACB1EQ64099050-4FD71D0B-B339-45F6-8CFB-878CD9532D9DQ64897716-0DA96F28-6AE3-4AA4-80F2-914F98B1B22BQ88002177-3921CB17-8D5E-4CE1-8926-7B4203602361Q91448177-68D0ECC1-87E9-4959-82DD-BBF55D10ECFBQ92039514-6CE3952C-E2D4-406F-B8AB-DA9B01CDF2DCQ92961461-0BB89FDA-C30B-49C1-A764-0282BCA9BBF1Q96294342-C32CD3D0-EFC0-4F13-9D44-A32D4A83C648
P50
description
researcher
@en
name
Theodosia Maina
@en
type
label
Theodosia Maina
@en
prefLabel
Theodosia Maina
@en
P31
P496
0000-0002-1123-2486